Sign inJoin waitlistJoin the waitlist

Farrukh Awan

Professor · University of Texas Southwestern Medical Center

Credentials: · · · · · ·

History

University of Texas Southwestern Medical Center
Present

Hematology and Medical Oncology
Ohio State University Hospital
2006–2009
UPMC
2003–2006
University of Pittsburgh Graduate School of Public Health
Aga Khan University Medical College Pakistan
1997–2001

Research

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2016 · 761 citations
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
JAMA Oncology · 2015 · 524 citations
BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia
Journal of Clinical Oncology · 2017 · 431 citations

JB
John Byrd
44 papers
Jennifer Woyach
39 papers
KR
Kerry Rogers
20 papers
JJ
Jeffrey Jones
19 papers
LA
Leslie Andritsos
18 papers
Mohamed Dabaja
18 papers
Kami Maddocks
16 papers
Craig Sauter
12 papers
Daniel Addison
12 papers · 4 as a fellow
Jennifer Brown
11 papers
Sairah Ahmed
11 papers
AH
Alex Herrera
10 papers

Clinical trials

IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
Principal investigator · Recruiting · Phase 1, Phase 2
University of Texas Southwestern Medical Center
2025–2030
Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia
Principal investigator · Completed · Phase 1
Xencor, Inc.
2010–2013
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Site PI · Unknown · Phase 1
TopAlliance Biosciences
2019–2026
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Sub-investigator · Recruiting · Phase 1, Phase 2
Eureka Therapeutics Inc.
2022–2027